A B S T R A C T The kidney adapts its tubular capacity to transport inorganic phosphate (Pi) 
Pi metabolism. Therefore the question arises whether the deficient production of 1,25-(OH)2D3 contributes to the alteration of the tubular transport of Pi observed in chronically TPTX rats. In the present investigation, vitamin D-replete rats were sham operated (SHAM) or thyroparathyroidectomized and then pair fed diets containing either 0.2 or 1.2 g/100 g P for 7 days. During this period, groups of SHAM and TPTX rats received i.p. 2 x 13 pmol/day of 1,25-(OH)2D3, a dose which was shown to just normalize the decreased intestinal absorption of Ca and Pi in TPTX rats. The capacity of tubular Pi transport was then assessed by measuring the fractional excretion of Pi (FEPi) at increasing plasma Pi concentration ([Pi]p,) obtained by acute infusion of Pi. The results show that in SHAM rats fed either P diet, 1,25-(OH)2D3 has no effect on the renal handling of Pi. In TPTX rats fed 1.2 g/100 g P diet, 1,25-(OH)2D3 increases FEPi over a wide range of [Pi] pl. In TPTX rats fed a 0.2 g/lOO g P diet, 1,25-(OH)2D3 does not alter FEPi up to a [Pi]pl of 3.0-3.5 mM, but does increase it at higher [Pi]p,. In fact, on both diets TPTX rats supplemented with 1,25-(OH)2D3 appear to have the same renal handling of Pi as SHAM counterparts. The effect of 1,25-(OH)2D3 INTRODUCTION The kidney responds to variations in the dietary intake of inorganic phosphate (Pi)' by changing its tubular capacity to transport Pi (1) (2) (3) . This adaptative response can be observed in both intact and chronically thyroparathyroidectomized (TPTX) rats (1, 3) . However, the capability of the renal tubule to adapt to a high-Pi diet is diminished in TPTX rats (1, 3) . The reason for this reduced capability of adaptation after TPTX has not yet been established. TPTX or parathyroidectomy (PTX) causes a rapid and marked decrease in the fractional excretion of Pi (FEPi) (4) (5) (6) (7) . This effect can be observed within the first 3 h after the surgical procedure (7) . However, after the acute phase, FEP1 increases up to a steady-state value within 24-48 h after PTX (7, 8) . This rise in FEPi could well be interpreted as an adaptive response tending to normalize the handling of Pi. In chronic PTX or TPTX animals FEPi remains, nevertheless, lower than normal (4) (5) (6) (7) , in spite of the preservation of an operating adaptation mechanism (1, 2) . This incomplete readjustment of the tubular capacity could be attributed to the disappearance of the direct and rapid effect of PTH on the tubular Pi transport, which is probably mediated through the adenylate cyclase system (9 (13, 14) . The influence ofTPTX on intestinal Ca (15, 16) and P (14) absorption is very likely due to the decrease in the 1,25-(OH)2D3 production which occurs in these animals (10) . Therefore the minimal administered amount of 1,25-(OH)2D3 which will normalize the intestinal calcium absorption may be considered a physiological dose, since it will substitute for the reduced endogenous production of the vitamin D3 metabolite after the removal of the parathyroid gland.
METHODS
Male Wistar rats weighing 150-170 g and raised on a commercial chow food (Altromin 1314, Altrogge, Lage, Lippe, W. Germany) containing 1.2 g/100 g P, 1.1 g/100 g Ca, and 280 IU/ 100 g vitamin D3, with free access to tap water, were used. In a first series ofexperiments, these vitamin D-replete rats were fed 14 days before the renal study an experimental diet containing the same amount of P and Ca, i.e., 1.2 g/100 g P and 1.1 g/100 g Ca. This diet was prepared by the addition of sodium phosphate and calcium gluconate to a basic diet (Altromin C-1730) containing 0.2 g/100 g P and 0.1 g/100 g Ca. 6 days after starting the experimental diet, the rats were either thyroparathyroidectomized or sham operated under ether anesthesia. Then during the 8 days preceding the renal study, the rats were either maintained under the experimental diet containing 1.2 g/100 g P and 1.1 g/100 g Ca or pair fed 0.2 g/100 g P and 1.1 g/100 g Ca prepared from the same basic food (Altromin C-1730). The sodium content was kept constant by adding NaCl to the low-P diet. The day after the surgical procedure, the rats 1420 J-P. Bonjour, C. Preston, and H. Fleisch were given a first i.p. injection of either 13 pmol ofchemically synthetized 1,25-(OH)2D32 dissolved in 25 ,ul of95% ethanol or the ethanol vehicle alone. This treatment was given during the next 6 days twice daily between 8 and 9 a.m. and 4 to 5 p.m. On the day of the renal study, the last injection was given at 8 a.m., 90 min before starting the equilibration period of the clearance experiment.
In a second set of experiments, the influence of 25-OHD32 on the renal handling of Pi was studied instead of 1,25-(OH)2D3. TPTX rats fed the 1.2 g/100 g P experimental diet received i.p. 14 injections of 25-OHD3 in doses of 130 and 1,300 pmol dissolved in 25 ,ul of 95% ethanol. A group of pair-fed animals were injected i.p. with the ethanol vehicle as described above.
In order to reduce the dead space of the urinary tract, in all experiments a subtotal cystectomy was done under ether anesthesia 48 h before the renal study, as previously described (1, 17) . After the clearance study the treatment was stopped and all rats were returned to the usual lab chow for 15 days. After this period the animals were fasted overnight and a blood sample was taken from the tip of the tail. Only data of TPTX rats displaying a plasma calcium concentration below 1.88 mM (7.5 mg/100 ml) have been considered for this study.
Clearance experiments. In both series ofexperiments, the renal clearance study was started at the same time (9:30 a.m.). The general methodology of the clearance measurement in conscious rats has been described earlier (1, 17 (1, 17) .
In one series of experiments, urine was collected under xylol and pH was measured. In another series, the excretion rate of cyclic AMP was determined in SHAM or TPTX rats with or without 1,25-(OH)2D3 treatment as mentioned above.
Finally, in TPTX rats with or without 1,25-(OH)2D3 administration, the renal handling of Pi was also studied under marked extracellular volume expansion by infusing the isotonic solution at 20 instead of 4 ml/h. Analytical method. Urinary volume (V) was determined by weighing. The activity of [3H]inulin in plasma and urine was measured in a scintillation spectrometer. 20 ,ul of urine or 10 ,ul of plasma was added to vials containing 10 ml of a scintillation solution made of toluene, 600 ml; ethylene-glycomonoethylether, 400 ml; naphthalene, 80 g; and Butyl-PBD [2 -(4 -tert -butyl -phenyl) -5 -(4 -biphenylyl) - Pi was determined in plasma and urine and in the diets as phosphomolybdate after reduction with 10% ascorbic solution (18) .
Plasma Ca concentration was measured by complexometric titration with ethyleneglycol-bis-(2-aminoethyl)-tetraacetic acid (Coming Calcium Analyzer 940). Na concentration in plasma and urine was determined by flame photometry (EEL, flame photometer, Evans Electroselenium Ltd., Halstead, England). The diets were analyzed after incineration of the samples and dissolution of the ash in 0.1 N HCI. The osmolality of solutions for infusion was measured with an Advanced Osmometer (model 3W, Advanced Instruments, Inc., Needham Heights, Mass.). Urinary cyclic AMP was determined by competitive binding assay using a commercial kit (cyclic AMP assay kit, The Radiochemical Centre, Amersham, England).
Statistical analysis. The experimental results are expressed as mean values ±SEM. The significance of the differences between groups were evaluated by two-sided Student's t test.
RESULTS
In SHAM rats, the chronic administration of 1,25-(OH)2D3 (2 x 13 pmol/day i.p. for 7days) does not appear to have any significant influence on the renal handling of Pi under either diet, as shown in Table I and Fig. 1 . Fig. 1 also shows that in intact rats the dietary- )hate infusion in sham-operated (SHAM) rats pair fed fect on urine pH (Table III) .
and low-P diet and treated or not with 1,25-(OH)2D3
To investigate whether the adenylate cyclase system 3 pmol/day i.p. for 7 days). Other data concerning these was involved in the 1,25-(OH)2D3 effect, we deter-,roups of rats are presented in Table I . mined urinary excretion of cyclic AMP in groups of SHAM and TPTX rats with or without 1,25-(OH)2D3 zed change in the transport capacity that has been treatment and pair fed the 1.2 g/100 g P diet. As shown ously described (1) is not affected by the chronic in Table IV , the expected difference in cyclic AMP nistration of 1,25-(OH)2D3. However, 1,25-excretion between SHAM and TPTX rats was not modi-12D3 given to SHAM rats fed the low-P diet en-fied by the administration of 1,25-(OH)2D3. Thus the es significantly the level of plasma Pi measured increase in the capacity to excrete Pi in TPTX rats reig the 0.15 M NaCl infusion (2.39+0.14 vs. 1.89 ceiving 1,25-(OH)2D3 and fed a 1.2 g/100 g P diet was 9 mM, P < 0.01, Table I) .
not associated with an increased excretion of cyclic TPTX rats fed a 1.2 gIl00 g P diet (Fig. 2) (Fig. 3) . Indeed, during the last period of clearance, when plasma Pi was similar in both groups, Pi excretion (UVP1/ml glomerular filtration) was significantly (P < 0.01) enhanced in the animals treated with 1,25-(OH)2D3 (Table II) . Again the relationship between plasma Pi and FEPi appears to be very similar in SHAM and TPTX rats supplemented with 1,25-(OH)2D3 (Fig. 3) Variation in plasma Ca has been shown to be associated with alteration in the renal handling of phosphate (6) . The values of plasma calcium obtained at the end of the first and last clearance periods are presented in Table VI . In rats fed the 1.2 g/100 g P diet, 1,25-(OH)2D3 abolished the difference in plasma calcium between SHAM and TPTX rats, when assessed during the infusion of isotonic saline. Under acute Pi infusion, the fall in plasma calcium was smaller in SHAM than in TPTX + 1,25-(OH)2D3, so that the calcemia was significantly lower in the latter group during the last period of clearance (Table VI) . In TPTX rats fed the 0.2 g/100 g P diet, plasma calcium assessed under either isotonic saline or Pi infusion was not higher in the 1,25-(OH)2D3-treated group than in the control group (Table VI) ing to a high-Pi diet (1, 3) in chronically TPTX rats is due to the reduced production of 1,25-(OH)2D3 (10) . Such a possibility would imply that parathyroid hormone may affect the tubular capacity to transport Pi by two distinct mechanisms: a rapid action mediated probably through the adenylate cyclase system (9), and a long-term influence by affecting the production of 1,25-(OH)2D3. Our results confirm that 1,25-(OH)2D3 can exert opposite effects on the phosphatemia according to the phosphate status of the animals (19). On a low-Pi diet, 1,25-(OH)2D3 induces an elevation in plasma Pi which cannot be attributed to a change in the renal capacity to transport Pi but could be due to an increase in bone resorption (21, 22) . On the other hand, the fall in the phosphatemia (19) which occurs in TPTX rats fed a normal or high-P diet could be due, in full or in part, to a change in the renal handling of Pi.
The mechanism whereby 1,25-(OH)2D3 affects the renal handling of Pi does not seem to be related to a change in tubular acidification. Indeed, the overall alteration in the renal handling of Pi is not associated with any consistent change in the urinary pH. Nor can the change in the renal handling of Pi be explained by an alteration in the tubular transport of sodium resulting from variations in ECVE. Indeed, in TPTX rats conspicuous changes in ECVE cannot produce such a prominent change in the tubular Pi transport as that observed in TPTX rats supplemented with 1,25-(OH)2D3 (Table V) . Furthermore, the change in the renal handling of Pi observed under marked ECVE is associated with a significant increase in water excretion and an elevation in the fractional excretion of calcium which cannot be explained by alteration in filtered load (6). This was not the case for water excretion in our rats treated with 1,25-(OH)2D3 (Table III) , and the increased calciuria observed can be entirely accounted for by the increased filtered load of calcium (23) .
Although cyclic AMP excretion might not reflect in all circumstances the activity of the renal adenylate cyclase, our data suggest that the effect was not due to a stimulation of this system, since the rate of urine cyclic AMP excretion was not modified by the administration of 1,25-(OH)2D3.
Acute elevation of plasma calcium has been shown to be accompanied variously by an increase (24, 25) and a decrease (26) (27) (28) All values are means±SEM. Animals were fed a 1.2 g/100 g P diet.
* 2 x 13 pmol/day i.p.
4 P < 0.001 with respect to the corresponding group receiving the ethanol vehicle alone. For comparison, the results obtained at similar plasma [Pi] in rats infused at 4 ml/h are also presented. They correspond to the data presented in Table II and Fig. 2 (35) or in PTX animals (36, 37) . Thus, Albright and Reifenstein (35) found that 400,000 U of vitamin D2 given to a hypoparathyroid patient led to an increase in urinary Pi which was associated with a decrease in serum Pi. Similar results were found by Crawford et al. (36) in PTX rats, wherein the administration of 10,000-100,000 U of vitamin D2/day (625-6250 nmol/day) increased the fractional excretion of Pi for a given filtered load. Likewise, Ney et al. (37) found in vitamin D-deficient PTX dogs that 24 h after the administration of 100,000 U of vitamin D2 i.m., or 6 or more days after the administration of 30,000 U daily, the urinary excretion of Pi increased about 10 times, while the filtered load remained constant. Therefore, it is quite possible that the effects described above pertain to the same mechanism as those we have observed under 1,25-(OH)2D3 treatment in TPTX rats receiving a normal supply of phosphate. As with the intestinal or bone response to vitamin D metabolites (11) Finally, our results obtained in TPTX rats are also consistent with a very recent clinical observation made in children with hypoparathyroidism (38) indicating that chronic treatment with small doses of 1,25-(OH)2D3 (72-96 pmol/kg per day, a dose very similar to that used in the present study) also promotes a decrease in the plasma Pi level while it concomitantly increases the renal clearance of Pi. This suggests that in humans as in rats the physiological role of 1,25-(OH)2D3 on the renal handling of Pi is not to stimulate the reabsorption of this ion, but to maintain the full capability of the renal tubule for adapting to variations in the Pi load of the organism. The process whereby 1,25-(OH)2D3 interacts, directly or indirectly, with the tubular Pi transport deserves to be further explored.
